“showed a trend”

In qRT-PCR, statistically significant effects of GLY on gene expression were detected for CDH2 (p = 0.012) and ERRFI (p = 0.021) comparing GLY HC and CON HC , while changes in LURAP1L expression showed a trend (p = 0.074).

However, A7173C showed a trend to associate with cervical cancer ( P =0.074) in the A1-A3 (EUR) variants (case: 0% vs control: 15%).

Overall, ASD-V showed a trend towards delayed M100 latency compared with TD ( p = 0.074), with post hoc t tests showing significant delays in ASD-V compared to TD in the right hemisphere ( p = 0.039) consistent with prior reports [ 42 ] and similar to M50 findings.

Patients with persistent SL-TAC showed a trend for a decreased risk of dnDSA at 1 year post-transplantation that did not reach significance ( P = 0.074).

The >90 day group also showed a trend toward decreased rates of partial flap failure (OR 0.22, p =0.074).

As expected, we found that patients with lower baseline observed species and Chao1 indices had significantly prolonged PFS ( p = 0.0015 for observed species and p = 0.013 for Chao1, Figure 1C ), and patients with a lower Shannon index also showed a trend towards increased PFS ( p = 0.074, Figure 1C ) in those who received immunotherapy combined with chemotherapy.

In a stage-adjusted Cox model, strong TLR4 expression showed a trend to association with a better prognosis; in the tumour front, the HR for overall survival was 1.8 ( P = 0.074, 95%CI: 0.9-3.3), and in the tumour bulk, it was 1.7 ( P = 0.059, 95%CI: 1.0-3.1).

When correlating brain activation with praxis test scores, the mean T-values of the frontal ROI showed a trend towards a negative correlation with the De Renzi Ideomotor apraxia scores (R = −.297, P = .074).

The pentoxifylline group showed a trend toward decreased albuminuria (3 months: 15 % decrease (−38 to 15) vs. 9 % increase (−30 to 44), p = 0.074; 6 months: 19 % decrease (−57 to 30) vs. 3 % increase (−41 to 57), p = 0.072).

A similar study with 435 patients comparing oral ibandronate 50 mg with placebo showed a trend towards improved pain scores and decreased analgesic use (p = 0.074) but did not reach statistical significance ( Tripathy et al 2004 ).

In multivariable logistic regression ( N = 243, AIC = 329.73), insurance category (OR 1.58, 95% CI 0.84–2.98, p = 0.159), age (OR 0.99, p = 0.454), sex (OR 1.58 for male, p = 0.120), and race were not independently significant, though Black/African American race showed a trend toward higher attendance (OR 2.31, 95% CI 0.92–5.78, p = 0.074).

Bone metastasis showed a trend toward shorter PFS (HR = 2.43; 95% CI, 0.92–6.41; p = 0.074) but did not reach significance for OS (HR = 2.04; 95% CI, 0.63–6.55; p = 0.233) ( Supplementary Table S3, Supplementary Figure S1A,B ). 3.4.

Higher amyloid PET SUVR showed a trend toward association with lower plasma Aβ42 levels (standardized β = −0.15, 95% CI [−0.31, 0.01], p = 0.074) (Figure 3A ) and was significantly associated with higher pTau181 (standardized β = 0.26, 95% CI [0.10, 0.42], p = 0.001) (Figure 3B ).

In contrast, for LS BMD, ALDH2 genotype independently exerted a significant effect (P = 0.012), and the interaction between genotype and treatment duration showed a trend toward significance (P = 0.074).

Primary prophylactic IVIG use showed a trend toward lower CMV reactivation ( p = 0.074).

Furthermore, the patients with anti-osteoporotic treatment showed a trend ( p = 0.074) towards having experienced a previous fracture more frequently.

MC density did not correlate with MYD88 nor CXCR4 mutational status but MYD88 WT patients showed a trend toward a lower MC density (40.9 vs . 90.6 for MYD88 L265P patients, p = 0.0742; size effect 0.61 [–0.24; 1.45]). 3.4.

Glimmix analysis showed a trend of interacting effects of photic environment and walking activity of males and females ( P = 0.0743).

Intratumoural PD-1 status was not associated with OS overall, although PD-1 + AS showed a trend towards poorer survival ( p = 0.0745; Supplementary Figure S4A–D ).

In addition, two connections showed a trend, the posterior part of the cingulate-anterior part of the retrosplenial cortex with the frontal cortex ( p = 0.0745) and the posterior part of the retrosplenial cortex with the parietal association cortex ( p = 0.0514).

The LN+ group showed a trend toward higher Risk-Score compared to the LN- group, with median values of 93.0 and 76.8, respectively ( p = 0.075) (Fig. 4 a).

In a further subgroup analysis, patients with permanent treatment discontinuation due to immune-related toxicity (40/41 were evaluable) showed a trend toward prolonged OS, albeit without statistical significance (p=0.075, Supplementary Figure S2 ). 4.

PPAR-α and Gro-α also showed a trend of overexpression in CRC, with p -values slightly above 0.05 ( p = 0.075 and 0.068, respectively).

MD+SPS animals receiving DK‐I‐56‐1 traveled a longer distance (adjusted p = 0.0361, q = 3.901; Figure 2a ) and showed a trend toward more rotations (adjusted p = 0.075, q = 3.479; Figure S2 ) compared with MD+SPS‐VEH.

While no significant differences in task accuracy were observed among overweight, obese, and normal-weight participants ( p > 0.05), reaction times improved significantly in the OV-E ( p < 0.05) and showed a trend toward improvement in the OB-E ( p = 0.075), indicating enhanced task efficiency.